Review: taking Risperdal and Aricept together


Summary

Drug interactions are reported among people who take Risperdal and Aricept together. This review analyzes the effectiveness and drug interactions between Risperdal and Aricept. It is created by eHealthMe based on reports of 1,045 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Risperdal and Aricept >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Risperdal

Risperdal has active ingredients of risperidone. It is often used in schizophrenia. (latest outcomes from Risperdal 44,527 users)

Aricept

Aricept has active ingredients of donepezil hydrochloride. It is often used in dementia alzheimer's type. (latest outcomes from Aricept 16,215 users)

On Aug, 22, 2016

1,045 people who take Risperdal, Aricept are studied.


Number of reports submitted per year:

Risperdal and Aricept drug interactions.

Drug effectiveness over time:

Risperdal:
  • < 1 month: 0.0% - (0 of 1 people)
  • 1 - 6 months: 16.0% - (1 of 6 people)
  • 6 - 12 months: 0.0% - (0 of 1 people)
  • 1 - 2 years: 33.0% - (1 of 3 people)
  • 2 - 5 years: 25.0% - (1 of 4 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)
Aricept:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 2 people)
  • 6 - 12 months: 33.0% - (1 of 3 people)
  • 1 - 2 years: 25.0% - (1 of 4 people)
  • 2 - 5 years: 66.0% - (2 of 3 people)
  • 5 - 10 years: 0.0% - (0 of 2 people)
  • 10+ years: 0.0% - (0 of 1 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Risperdal:
  • female: 23.0% - (3 of 13 people)
  • male: 0.0% - (0 of 2 people)
Aricept:
  • female: 25.0% - (3 of 12 people)
  • male: 33.0% - (1 of 3 people)

Drug effectiveness by age:

Risperdal:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 100.0% - (1 of 1 people)
  • 60+: 14.0% - (2 of 14 people)
Aricept:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 26.0% - (4 of 15 people)

Most common drug interactions over time *:

< 1 month:
  • pulmonary embolism
  • aggression
  • somnolence
  • pneumonia
  • dehydration
  • thrombocytopenia
  • hepatic function abnormal
  • lethargy
  • loss of consciousness
  • anxiety
1 - 6 months:
  • aggression
  • agitation
  • gait disturbance
  • coma
  • fall
  • loss of consciousness
  • brain stem infarction
  • drug ineffective
  • syncope
  • urinary tract infection
6 - 12 months:
  • agranulocytosis
  • type 2 diabetes mellitus
  • urinary tract infection
  • confusional state
  • pleurothotonus
  • agitation
  • anaemia
  • cerebrovascular accident
  • convulsion
  • death
1 - 2 years:
  • speech disorder
  • arrhythmia
  • confusional state
  • bradycardia
  • blood cholesterol increased
  • cardiac disorder
  • cardio-respiratory arrest
  • coma
  • coordination abnormal
  • decubitus ulcer
2 - 5 years:
  • syncope
  • cerebral atrophy
  • fall
  • normal pressure hydrocephalus
  • cerebral ventricle dilatation
  • confusional state
  • sick sinus syndrome
  • cardio-respiratory arrest
  • diarrhoea
  • hepatic function abnormal
5 - 10 years:
  • back pain
  • chest pain
  • hyperkeratosis
  • onychomycosis
  • polysubstance dependence
  • schizophrenia
  • cellulitis
  • dementia alzheimer's type
  • arteriosclerosis coronary artery
  • asthma
10+ years:
  • agitation aggravated
  • emotional poverty
  • hallucination, auditory
  • somnolence
  • teeth grinding and clenching
  • weakness
not specified:
  • fall
  • confusional state
  • agitation
  • somnolence
  • sedation
  • dehydration
  • aggression
  • gait disturbance
  • hypotension
  • dementia

Most common drug interactions by gender *:

female:
  • fall
  • confusional state
  • urinary tract infection
  • gait disturbance
  • convulsion
  • agitation
  • tremor
  • hypotension
  • somnolence
  • serotonin syndrome
male:
  • dehydration
  • aggression
  • fall
  • sedation
  • somnolence
  • agitation
  • dementia
  • depressed level of consciousness
  • lethargy
  • asthenia

Most common drug interactions by age *:

0-1:
  • cardiac failure congestive
  • arteriovenous graft thrombosis
  • bradycardia
  • cardio-respiratory arrest
  • coma
  • convulsion
  • death
  • decubitus ulcer
  • diabetes mellitus
  • gastrointestinal haemorrhage
2-9:
  • drug ineffective
  • simple partial seizures
20-29:
  • autonomic nervous system imbalance
  • confusional state
  • creatine phosphokinase decreased
  • depressed level of consciousness
  • fatigue
  • muscle rigidity
  • myalgia
30-39:
  • cerebral atrophy
  • confusional state
  • diabetes mellitus
  • libido decreased
  • migraine
  • psychotic disorder
  • somnolence
  • tooth impacted
  • weight increased
  • abasia
40-49:
  • convulsion
  • type 2 diabetes mellitus
  • arteriosclerosis coronary artery
  • asthma
  • back pain
  • cellulitis
  • chest pain
  • dementia alzheimer's type
  • hyperkeratosis
  • onychomycosis
50-59:
  • back pain
  • confusional state
  • normal pressure hydrocephalus
  • insomnia
  • chronic obstructive pulmonary disease
  • gait disturbance
  • cerebrovascular accident
  • psychotic disorder
  • restless legs syndrome
  • cerebral atrophy
60+:
  • fall
  • dehydration
  • agitation
  • aggression
  • confusional state
  • somnolence
  • sedation
  • gait disturbance
  • hypotension
  • tremor

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Risperdal and Aricept?

Can you answer these questions?

More questions for: Risperdal, Aricept

You may be interested in these reviews

More reviews for: Risperdal, Aricept

On eHealthMe, Risperdal (risperidone) is often used to treat schizophrenia. Aricept (donepezil hydrochloride) is often used to treat dementia alzheimer's type. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.